Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

TAP President Will Be Former Sales VP Alan MacKenzie

Executive Summary

Former TAP VP-sales Alan MacKenzie will become president of the company effective Sept. 1

You may also be interested in...



HGS CEO hails from TAP

Former TAP Pharmaceuticals President Thomas Watkins joins Human Genome Sciences as CEO. Watkins worked for Abbott-affiliated companies for almost 20 years, including six years serving as president of the Takeda/Abbott joint venture; his term as president was limited by the joint venture agreement (1"The Pink Sheet" Sept. 6, 2004, p. 8). Watkins replaces former HGS CEO William Haseltine, PhD, who also retired as chairman; Argeris Karabelis, PhD, became chairman Oct. 17...

HGS CEO hails from TAP

Former TAP Pharmaceuticals President Thomas Watkins joins Human Genome Sciences as CEO. Watkins worked for Abbott-affiliated companies for almost 20 years, including six years serving as president of the Takeda/Abbott joint venture; his term as president was limited by the joint venture agreement (1"The Pink Sheet" Sept. 6, 2004, p. 8). Watkins replaces former HGS CEO William Haseltine, PhD, who also retired as chairman; Argeris Karabelis, PhD, became chairman Oct. 17...

TAP Execs Acquitted Of Conspiracy Charges Related To Marketing Practices

The acquittal of eight current and former TAP employees on conspiracy charges suggests that the perception of shifting standards for marketing compliance will make it difficult for prosecutors to translate corporate settlements into convictions of individual executives

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044625

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel